Hetero Drugs South Africa has acquired a controlling stake in Barrs Pharmaceuticals, a strategic development that supports Barrs’ exit from business rescue and ensures continuity of critical government tenders. The acquisition is expected to strengthen the supply of essential and life-saving medicines in South Africa, including treatments for HIV/AIDS, and further reinforce the country’s healthcare ecosystem through enhanced pharmaceutical capacity and stability.